Drug interactions
Dacarbazine + Sipuleucel-t
Severity: Moderate
Dacarbazine and Sipuleucel-t: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Sipuleucel-T depends on the patient's own immune cells to generate an anti-tumor response. Cytotoxic or immunosuppressive chemotherapy such as dacarbazine may impair that response.
What this interaction means in plain words
Dacarbazine and Sipuleucel-t can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Myelosuppressive and immunosuppressive effects of dacarbazine may reduce the immune cell activation that sipuleucel-T relies on.
What to do
Avoid concurrent immunosuppressive chemotherapy around leukapheresis and infusion where possible. Discuss sequencing with the oncology team.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dacarbazine and Sipuleucel-t, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Dacarbazine
Frequently asked questions
Can I take Dacarbazine with Sipuleucel-t?
MediHelp rates the interaction as moderate. Dacarbazine and Sipuleucel-t can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sipuleucel-T depends on the patient's own immune cells to generate an anti-tumor response. Cytotoxic or immunosuppressive chemotherapy such as dacarbazine may impair that response.
How serious is the interaction between Dacarbazine and Sipuleucel-t?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent immunosuppressive chemotherapy around leukapheresis and infusion where possible. Discuss sequencing with the oncology team.
What other medicines interact with Dacarbazine?
MediHelp also lists interactions of Dacarbazine with, for example, Adenovirus types 4 and 7 live, Axicabtagene ciloleucel, Belatacept. The full list is on the Dacarbazine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
